According to a recent market study published by Growth Market Reports, titled, “Global Skin Substitutes Market by Type, By Origin, By Application, By End-user and By Region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 1,781.7 Million in 2022 and is anticipated to expand at a growth rate of 13.6% by 2031.

Get Sample Report @ https://growthmarketreports.com/request-sample/5650

Skin substitutes ideally possess the composition and function of the skin or have the potential for autologous regenerative healing when applied to a wound. Skin substitutes provide a unique solution for difficult-to-treat wounds. Each skin substitute has its own unique set of advantages and disadvantages. Wound healing tends to be unique to the individual, hence, the use of skin substitutes is highly personalized, depending upon the type of wound (acute or chronic), its etiology (trauma or chronic inflammation), and the skin component (epidermis, dermis, or both) that requires replacement.

The Global Skin Substitutes Market has been segmented in terms of type, origin, application, end-user, and region. In terms of type, the Global Skin Substitutes Market is split into Acellular, Cellular Allogeneic, Cellular autologous, Xenograft, and Others. On the basis of Origin, the market is fragmented into Human Dermis, Porcine Dermis, and Bovine Dermis. On the basis of Application, the market is fragmented into Acute Wounds and Chronic Wound. On the basis of end-user, the market is fragmented into Hospitals, Ambulatory Surgical Centers, and Clinics. Considering regions, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The COVID-19 pandemic’s impact on the skin substitutes market is severe. Elective surgeries that involve skin substitutes, such as skin grafts or skin substitutes made from human or animal cells, are often non-urgent and are delayed without significant harm to the patient. In 2021, approximately 10 Million of the population in the UK were waiting for surgical treatments, up from 4 Million before the pandemic.

Key Takeaways from the Study:

  • Players in the Global Skin Substitutes Market include Mölnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Organogenesis Holdings Inc, Tissue Regenix Group plc, MIMEDX Group, Inc, Mallinckrodt plc, HansBiomed Corp., Reprise Biomedical Inc., Bioventus Inc., PolyNovo Limited, BioHorizons, Harbor MedTech, Inc., Regenity, and Smith+Nephew.

  • Improving healthcare infrastructure is expected to create opportunities in the coming years.

  • Based on type, the market is segmented into Acellular, Cellular Allogeneic, Cellular autologous, Xenograft, and Others. The Acellular segment is expected to hold a considerable share of the market during the forecast period. Cellular allogeneic skin substitutes contain living cells that promote rapid tissue regeneration. This is especially beneficial in cases of severe burns, chronic wounds, and others.

  • Based on the origin, the market is segmented into human dermis, porcine dermis, and bovine dermis. The human dermis segment is anticipated to expand at a significant CAGR during the forecast period. Acellularized porcine dermis is a readily available material associated with minimal immunogenicity. Porcine dermis is used as a temporary wound covering for partial-thickness and full-thickness burn wounds. Its wide availability, low cost, ability to be harvested in large quantities, and excellent handling properties are anticipated to drive the segment in the coming years.

  • Based on the application, the market is segmented into acute wounds and chronic wound. The chronic wound segment is anticipated to expand at a significant CAGR during the forecast period. The acute wounds segment is registering a significant growth, owing to the rising thermal, chemical, or electrical burn incidences across the globe. These burns eventually damage the skin, and thus, leads to acute wounds. Additionally, rising cases of acute wounds drive the demand of skin substitutes considerably.

  • Based on the end-user, the market is segmented into hospitals, ambulatory surgical centers, and clinics. The hospitals segment is anticipated to expand at a significant CAGR during the forecast period. The ambulatory surgical centers segment registers a substantial growth in the skin substitutes market, due to the rising demand for outpatient procedures.

  • Based on regions, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a significant share of the market in 2022. Rising prevalence of chronic wound, such as diabetic foot ulcer drives the demand for skin substitutes in the region. For instance, as per Health Innovation Program, 2020 approximately 2 million people in the US develop a diabetic foot ulcer each year.

Report Scope:

Report Metric

Details

Market Value in 2022

US$ 1,781.7 Million

Market Growth Rate (from 2022 to 2031)

13.6%

Historical Data

2016 & 2021

Base Year

2022

Forecast Period

2023 – 2031

Units Considered

Value (US$ Million)

Market Segments

By Type, By Origin, By Application, By End-user, and By Region

Key Companies Profiled

Mölnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Organogenesis Holdings Inc, Tissue Regenix Group plc, MIMEDX Group, Inc, Mallinckrodt plc, HansBiomed Corp., Reprise Biomedical Inc., Bioventus Inc., PolyNovo Limited, BioHorizons, Harbor MedTech, Inc., Regenity, and Smith+Nephew.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet your research requirements.

 

Target Audience:

  • Supply-side: Vendor, Manufacturer, Distributors, Supplier, Retailer.

  • Regulatory Side: Concerned government authorities, and other approved regulatory bodies.